Once the diagnosis is established, a therapeutic approach is determined. This approach aims to address various aspects of migraine. It takes into account factors such as the assessment and treatment of mood disorders, stress reduction, and the alleviation of migraine-related pain. Throughout this treatment, the patient must maintain good sleep hygiene and avoid identified triggers.
For more information, we invite you to read our articles on migraine and sleep, as well as meditation and migraine. They can help you naturally reduce the impact of your migraine on your daily life.
In recent years, there have been significant developments in new migraine treatments, including Botox and anti-CGRP medications. These treatments offer hope for chronic migraine patients.
An American study conducted in 2013 by the Allergan laboratory suggests that botulinum toxin (Botox) is a treatment specifically designed for preventing headaches in adults with chronic migraine. Botulinum toxin gradually relaxes the muscles, which provides relief from migraines, according to the study.
This treatment reduces various dimensions of migraine, including symptoms, headache frequency, and intensity. Typically, three injections of the treatment are required to assess its effectiveness. Patients who continue the treatment often experience a reduction in symptoms after receiving five injections.
On the other hand, anti-CGRP medications are part of a new generation of drugs known as monoclonal antibodies. During a migraine attack, a substance called CGRP (calcitonin gene-related peptide) is released in the brain, and this protein is responsible for pain. CGRP promotes blood vessel dilation and inflammation. Anti-CGRP drugs recognize this molecule and neutralize its effects.
People who have failed to respond to other therapies and experience 8 or more days of migraine per month are eligible for this treatment. It typically involves a monthly injection, either subcutaneously or intravenously.
The treatment of chronic migraine involves a proper diagnosis, which depends on good communication and a thorough consideration of the patient’s triggers and symptoms. It is essential to record your migraine attacks with the necessary information and evaluate the long-term impact of your migraine to establish a correct diagnosis of chronic or severe migraine and offer you the appropriate treatment. Apo is here to assist you with that.
As we have seen in this article, chronic migraine is more challenging to manage than episodic migraine. According to the SFEMC, 3% of episodic migraineurs unfortunately develop chronic migraine each year.
The Apo Team is considering the possibility of offering a slightly different version of the Apo application, potentially with daily information input for chronic migraine sufferers or for episodic migraine sufferers experiencing a deterioration in their condition, to help them closely monitor their migraine and gradually take control of it.